浏览全部资源
扫码关注微信
右美托咪定对大鼠热/冷缺血后供肾的保护作用及机制研究
Protective effects and mechanisms of dexmedetomidine on kidney donors after warm/cold ischemia in rats
- 局解手术学杂志 2024年33卷第9期 页码：778-782
- 作者机构：
陆军军医大学附属新桥医院泌尿外科，重庆 400037
- 作者简介：
宋亚军，E-mail：332878249@qq.com
- 基金信息：重庆市自然科学基金面上项目(cstc2021jcyj-msxm X0611);重庆市博士“直通车”科研项目(CSTB2022BSXM-JCX0007)
DOI：10.11659/jjssx.02E024074
中图分类号： R322.61;R617;R971.3纸质出版日期：2024-09-25，
收稿日期：2024-02-29，
- 稿件说明：
移动端阅览
邹基凤,盛浩,肖亚等.右美托咪定对大鼠热/冷缺血后供肾的保护作用及机制研究[J].局解手术学杂志,2024,33(09):778-782.
ZOU Ji-feng,SHENG Hao,XIAO Ya,et al.Protective effects and mechanisms of dexmedetomidine on kidney donors after warm/cold ischemia in rats[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2024,33(09):778-782.
邹基凤,盛浩,肖亚等.右美托咪定对大鼠热/冷缺血后供肾的保护作用及机制研究[J].局解手术学杂志,2024,33(09):778-782. DOI： 10.11659/jjssx.02E024074.
ZOU Ji-feng,SHENG Hao,XIAO Ya,et al.Protective effects and mechanisms of dexmedetomidine on kidney donors after warm/cold ischemia in rats[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2024,33(09):778-782. DOI： 10.11659/jjssx.02E024074.
摘要
目的
2
探索右美托咪定（Dex）对大鼠热缺血、冷缺血后供肾的保护作用及其潜在机制。
方法
2
将21只雄性SD大鼠随机分为对照组、模型组（0 μmol/L Dex组）和Dex组（1 μmol/L Dex组），每组7只。采用放血法处死大鼠，热缺血30 min后摘取肾，对照组供肾直接固定或-80 ℃保存，模型组和Dex组供肾分别置于含0 μmol/L Dex和1 μmol/L Dex的威斯康星大学器官保存液中4 ℃冷藏24 h，模拟供肾冷缺血状态。肾组织行HE染色后观察形态学变化并进行组织损伤评分，比色法测定N-乙酰-β-D-氨基葡萄糖苷酶（NAG）活力，TUNEL法检测细胞凋亡情况，Western blot检测受体相互作用蛋白激酶3（RIPK3）蛋白表达水平，免疫荧光法测定磷酸化混合谱系激酶结构域样假激酶（pMLKL）表达水平。
结果
2
对照组肾小球、肾小管无明显异常，模型组部分肾小管扩张，肾小管上皮细胞扁平，Dex组肾小管损伤较模型组缓解。与对照组比较，模型组和Dex组肾损伤评分、NAG活性升高，TUNEL阳性凋亡细胞数增多，pMLKL和RIPK3表达水平增加（
P
<
0.05）。与模型组比较，Dex组肾损伤评分、NAG活性降低，TUNEL阳性凋亡细胞数减少，pMLKL表达水平下降（
P
<
0.05）。
结论
2
Dex对大鼠热缺血、冷缺血后供肾具有保护作用，其机制与减少细胞凋亡、抑制坏死性凋亡有关。
Abstract
Objective
2
To investigate the protective effects and mechanisms of dexmedetomidine （Dex） on kidney donors after warm ischemia and cold ischemia in rats.
Methods
2
A total of twenty-one male SD rats were randomly allocated into the control group， the model group （0 μmol/L Dex group） and the Dex group （1 μmol/L Dex group），with 7 rats in each group. All the rats were killed by bloodletting， the kidneys were extracted after 30 minutes of warm ischemia， and the kidneys of the control group were directly fixed or preserved at -80 ℃. The kidney donors of the model group and the Dex group were respectively refrigerated in the university of Wisconsin organ preservation solution containing 0 μmol/L Dex and 1 μmol/L Dex at 4 ℃ for 24 hours， to simulate the cold ischemia state of the kidney donors.HE staining was performed to observe the morphological changes and the tissue injury score was conducted.The activity of N-acetyl-β-D-glucosaminase （NAG） was determined by colorimetry， the apoptosis level was detected by TUNEL， the expression level of receptor-interacting protein kinase 3（RIPK3） was detected by Western blot， and the expression level of phosphorylation mixed lineage kinase domain like protein （pMLKL） was determined by immunofluorescence method.
Results
2
In the control group， there were no obvious abnormalities in glomerular or renal tubules. In the model group， some renal tubules were dilated and tubular epithelial cells were flattened. Compared with the model group， the damage of renal tubules in the Dex group was alleviated. Compared with the control group， kidney injury score， NAG activity， TUNEL positive cell number， pMLKL and RIPK3 expression levels were increased in the model group and the Dex group （
P
<
0.05）. Compared with the model group， kidney injury score， NAG activity， TUNEL positive cell number， and pMLKL expression level were decreased in the Dex group （
P
<
0.05）.
Conclusion
2
Dex has protective effects on kidney donors after warm ischemia and cold ischemia， and its mechanism is related to reducing apoptosis and inhibiting necroptosis.
关键词
热缺血冷缺血右美托咪定肾移植器官保护
Keywords
warm ischemiacold ischemiadexmedetomidinekidney transplantationorgan protection
references
Voora S，Adey DB.Management of kidney transplant recipients by general nephrologists：core curriculum 2019［J］.Am J Kidney Dis，2019，73（6）：866-879.doi：10.1053/j.ajkd.2019.01.031http://dx.doi.org/10.1053/j.ajkd.2019.01.031.
Zhao S，Wu W，Lin X，et al.Protective effects of dexmedetomidine in vital organ injury：crucial roles of autophagy［J］.Cell Mol Biol Lett，2022，27（1）：34.doi：10.1186/s11658-022-00335-7http://dx.doi.org/10.1186/s11658-022-00335-7.
Pefanis A，Ierino FL，Murphy JM，et al.Regulated necrosis in kidney ischemia-reperfusion injury［J］.Kidney Int，2019，96（2）：291-301.doi：10.1016/j.kint.2019.02.009http://dx.doi.org/10.1016/j.kint.2019.02.009.
Chen Q，Liu X，Liu Z，et al.Tackling regulated cell death yields enhanced protection in lung grafts［J］.Theranostics，2023，13（13）：4376-4390.doi：10.7150/thno.87375http://dx.doi.org/10.7150/thno.87375.
Roufosse C， Simmonds N， Clahsen-van Groningen M，et al. A 2018 reference guide to the Banff classification of renal allograft pathology［J］.Transplantation，2018，102（11）：1795-1814.doi：10.1097/TP. 0000000000002366http://dx.doi.org/10.1097/TP.0000000000002366.
Jia P，Teng J，Zou J，et al.miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice［J］.Anesthesiology，2013，119（3）：621-630.doi：10.1097/ALN.0b013e318298e5f1http://dx.doi.org/10.1097/ALN.0b013e318298e5f1.
Saeb-Parsy K，Martin JL，Summers DM，et al.Mitochondria as therapeutic targets in transplantation［J］.Trends Mol Med，2021，27（2）：185-198.doi：10.1016/j.molmed.2020.08.001http://dx.doi.org/10.1016/j.molmed.2020.08.001.
Nirala NR，Asiku J，Dvir H，et al.N-acetyl-β-d-glucosaminidase activity assay for monitoring insulin-dependent diabetes using Ag-porous Si SERS platform［J］.Talanta，2022，239：123087.doi：10.1016/j.talanta.2021.123087http://dx.doi.org/10.1016/j.talanta.2021.123087.
Knijff LWD，van Kooten C，Ploeg RJ.The effect of hypothermic machine perfusion to ameliorate ischemia-reperfusion injury in donor organs［J］.Front Immunol，2022，13：848352.doi：10.3389/fimmu.2022.848352http://dx.doi.org/10.3389/fimmu.2022.848352.
Ochando J，Ordikhani F，Boros P，et al.The innate immune response to allotransplants：mechanisms and therapeutic potentials［J］.Cell Mol Immunol，2019，16（4）：350-356.doi：10.1038/s41423-019-0216-2http://dx.doi.org/10.1038/s41423-019-0216-2.
Sanz AB，Sanchez-Niño MD，Ramos AM，et al.Regulated cell death pathways in kidney disease［J］.Nat Rev Nephrol，2023，19（5）：281-299.doi：10.1038/s41581-023-00694-0http://dx.doi.org/10.1038/s41581-023-00694-0.
徐斐，敖虎山.盐酸右美托咪定的临床应用［J］.中国循环杂志，2015，17（4）：401-403.doi：10.3969/j.issn.1000-3614.2015.04.025http://dx.doi.org/10.3969/j.issn.1000-3614.2015.04.025.
Bao N，Tang B.Organ-protective effects and the underlying mechanism of dexmedetomidine［J］.Mediators Inflamm，2020，2020：6136105. doi：10.1155/2020/6136105http://dx.doi.org/10.1155/2020/6136105.
Gao X，Wu Y.Perioperative acute kidney injury：the renoprotective effect and mechanism of dexmedetomidine［J］.Biochem Biophys Res Commun，2024，695：149402.doi：10.1016/j.bbrc.2023.149402http://dx.doi.org/10.1016/j.bbrc.2023.149402.
Sun M，Wang R，Xia R，et al.Amelioration of myocardial ischemia/reperfusion injury in diabetes：a narrative review of the mechanisms and clinical applications of dexmedetomidine［J］.Front Pharmacol，2022，13：949754.doi：10.3389/fphar.2022.949754http://dx.doi.org/10.3389/fphar.2022.949754.
Li J，Chen Q，He X，et al.Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through α（2）AR/PI3K/Akt pathway［J］.J Transl Med，2018，16（1）：78.doi：10.1186/s12967-018-1455-1http://dx.doi.org/10.1186/s12967-018-1455-1.
Si Y，Bao H，Han L，et al.Dexmedetomidine attenuation of renal ischaemia-reperfusion injury requires sirtuin 3 activation［J］.Br J Anaesth，2018，121（6）：1260-1271.doi：10.1016/j.bja.2018.07.007http://dx.doi.org/10.1016/j.bja.2018.07.007.
Zhu S，Lu Y.Dexmedetomidine suppressed the biological behavior of HK-2 cells treated with LPS by down-regulating ALKBH5［J］.Inflammation，2020，43（6）：2256-2263.doi：10.1007/s10753-020-01293-yhttp://dx.doi.org/10.1007/s10753-020-01293-y.
贾莉莉，王菲，翁亦齐，等.右美托咪定对肝缺血再灌注诱发大鼠肾损伤的影响［J］.中华麻醉学杂志，2016，36（2）：223-226.doi：10.3760/cma.j.issn.0254-1416.2016.02.026http://dx.doi.org/10.3760/cma.j.issn.0254-1416.2016.02.026.
Nagata S.Apoptosis and clearance of apoptotic cells［J］.Annu Rev Immunol，2018，36：489-517.doi：10.1146/annurev-immunol-042617-053010http://dx.doi.org/10.1146/annurev-immunol-042617-053010.
Seo J，Nam YW，Kim S，et al.Necroptosis molecular mechanisms：recent findings regarding novel necroptosis regulators［J］.Exp Mol Med，2021，53（6）：1007-1017.doi：10.1038/s12276-021-00634-7http://dx.doi.org/10.1038/s12276-021-00634-7.
Pasparakis M，Vandenabeele P.Necroptosis and its role in inflammation［J］.Nature，2015，517（7534）：311-320.doi：10.1038/nature 14191http://dx.doi.org/10.1038/nature14191.
0
浏览量
0
下载量
0
CSCD
- 网络PDF下载
- WORD下载
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
